Indian pharma industry likely to grow to $130 bn by 2030 https://ift.tt/5ASjIe0

The IDMA is working closely with the Government of India on PLI 2.0. A large part of imported medicine and equipment will be manufactured locally, decreasing dependence on imports and giving healthcare security to India. India is moving from being a generic manufacturing giant to value addition. Innovation, technology and entrepreneurship will drive India towards this said Dr Viranchi Shah, National President, Indian Drug Manufacturers Association.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/hTx5duS